Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP-AZITHROMYCIN 250 MG

AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) : 250 MG · DIN 02452308 · JAMP PHARMA CORPORATION

Health Canada status: MARKETED

What is JAMP-AZITHROMYCIN?

JAMP-AZITHROMYCIN 250 MG contains AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02452308, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-Sep-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02452308
Brand nameJAMP-AZITHROMYCIN
Generic / active ingredientAZITHROMYCIN (AZITHROMYCIN DIHYDRATE) : 250 MG
ManufacturerJAMP PHARMA CORPORATION
Strength250 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeJ01FA10 AZITHROMYCIN
AHFS class08:12.12.08
BiosimilarNo
Health Canada statusMARKETED
Status date29-Sep-2016
Original market date2016-09-29 00:00:00

Is AZITHROMYCIN in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by EUGIA PHARMA INC., last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for JAMP-AZITHROMYCIN

What can be used instead?

Other Canadian products sharing ATC code J01FA10 AZITHROMYCIN. 23 of 84 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AG-AZITHROMYCIN250 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02480700
APO-AZITHROMYCIN Z250 MGTABLETAPOTEX INCMARKETEDDIN 02415542
AURO-AZITHROMYCIN100 MG / 5 MLPOWDER FOR SUSPENSIONAURO PHARMA INCMARKETEDDIN 02482363
AURO-AZITHROMYCIN200 MG / 5 MLPOWDER FOR SUSPENSIONAURO PHARMA INCMARKETEDDIN 02482371
AZITHROMYCIN250 MGTABLET10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALSMARKETEDDIN 02545969
AZITHROMYCIN250 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETEDDIN 02442434
AZITHROMYCIN250 MGTABLETSANIS HEALTH INCMARKETEDDIN 02330881
AZITHROMYCIN FOR INJECTION500 MGPOWDER FOR SOLUTIONGENERIC MEDICAL PARTNERS INCMARKETEDDIN 02524449
AZITHROMYCIN FOR INJECTION500 MGPOWDER FOR SOLUTIONJAMP PHARMA CORPORATIONMARKETEDDIN 02523825
AZITHROMYCIN FOR INJECTION USP500 MGPOWDER FOR SOLUTIONSTERIMAX INCMARKETEDDIN 02483890

Who else supplies AZITHROMYCIN worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. AZITHROMYCIN appears in 4088 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for JAMP-AZITHROMYCIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for JAMP-AZITHROMYCIN

Health Canada Drug Product Database (DPD), DIN 02452308. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.